CARA – cara therapeutics, inc. (US:NASDAQ)

DELAYED 04:35 PM EDT 04/17/25


Volume Shares
1 Day Range
Volume Ratio
52 Week High	13.8055 01/11/25
52 Week Low	0.2257 12/19/24


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CARA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Wirk Shaheen

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Wirk Shaheen

Report

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Shah Sujal

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Shah Sujal

Report

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Larson Jeffrey Leroy

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Larson Jeffrey Leroy

Report

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: O'Brien Stephen Paul

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: O'Brien Stephen Paul

Report

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: WYZGA MICHAEL S

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: WYZGA MICHAEL S

Report

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Conn Avi Daniel

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Conn Avi Daniel

Report

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Chen Yixin

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Chen Yixin

Report

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Alibhai Imran Nizamudin

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Alibhai Imran Nizamudin

Report

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: HALL WALLACE L JR

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: HALL WALLACE L JR

Report

4/17

06:50 pm

cara

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Kauh John Saewook M.D.

Neutral Report

Form 4 Tvardi Therapeutics, For: Apr 15 Filed by: Kauh John Saewook M.D.

Report

4/17

06:31 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: O'Brien Stephen Paul

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: O'Brien Stephen Paul

Report

4/17

06:29 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: WYZGA MICHAEL S

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: WYZGA MICHAEL S

Report

4/17

06:27 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: HALL WALLACE L JR

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: HALL WALLACE L JR

Report

4/17

06:24 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Wirk Shaheen

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Wirk Shaheen

Report

4/17

06:23 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Conn Avi Daniel

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Conn Avi Daniel

Report

4/17

06:19 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Shah Sujal

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Shah Sujal

Report

4/17

06:16 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Kauh John Saewook M.D.

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Kauh John Saewook M.D.

Report

4/17

06:14 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Alibhai Imran Nizamudin

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Alibhai Imran Nizamudin

Report

4/17

06:11 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Smith Cynthia

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Smith Cynthia

Report

4/17

06:08 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Chen Yixin

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Chen Yixin

Report

4/17

06:06 pm

cara

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Larson Jeffrey Leroy

Neutral Report

Form 3 Tvardi Therapeutics, For: Apr 15 Filed by: Larson Jeffrey Leroy

Report

4/16

04:15 pm

cara

Form SCHEDULE 13D/A Tvardi Therapeutics, Filed by: Vifor (International) Ltd

Neutral Report

Form SCHEDULE 13D/A Tvardi Therapeutics, Filed by: Vifor (International) Ltd

Report

4/15

04:06 pm

cara

Form 8-K Tvardi Therapeutics, For: Apr 15

Low Report

Form 8-K Tvardi Therapeutics, For: Apr 15

Report

4/11

04:19 pm

cara

Form 8-K Cara Therapeutics, Inc. For: Apr 11

High Report

Form 8-K Cara Therapeutics, Inc. For: Apr 11

Report

4/1

04:30 pm

cara

Form 8-K Cara Therapeutics, Inc. For: Apr 01

Low Report

Form 8-K Cara Therapeutics, Inc. For: Apr 01

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.